Meldonium, EPO, and Advanced Performance Protocols

Meldonium: Restricting Fatty Acid Import

Meldonium (Mildronate) functions by inhibiting the enzyme gamma-butyrobetaine dioxygenase, thereby reducing the synthesis of carnitine. By lowering carnitine levels, Meldonium restricts the entry of long-chain fatty acids into the mitochondrial matrix.

From a bioenergetic standpoint, this is a highly strategic intervention. By blocking fat import, Meldonium:

• Forces the cell to switch to glucose oxidation.
• Relieves the intramuscular acyl-CoA gridlock.
• Reopens the Pyruvate Dehydrogenase (PDH) gateway, shifting the cell back to a highly oxidized, low-ROS state.

The EPO Synergy

Erythropoietin (EPO) stimulates red blood cell production, dramatically increasing the blood's oxygen-carrying capacity. When Meldonium is combined with EPO:

1. Meldonium ensures the cellular machinery is shifted away from oxygen-expensive fat oxidation and onto oxygen-efficient glucose oxidation.
2. EPO floods the system with ample oxygen.

This combination maximizes athletic output and cardiorespiratory endurance while minimizing the oxidative stress, cellular hypoxia, and lactic acid accumulation that normally limit physical performance.